Cultural advice

The Australian National University acknowledges, celebrates and pays our respects to the Ngunnawal and Ngambri people of the Canberra region and to all First Nations Australians on whose traditional lands we meet and work, and whose cultures are among the oldest continuing cultures in human history.

Aboriginal and Torres Strait Islander peoples are advised that ANU Library collections may include images, names, voices, and other representations of deceased persons.

Material in the collection may contain terms, language or views that reflect the period in which the item was created and may be considered inappropriate today.

Examining progression-free survival in first- and second-line treatment for BRAF-mutant metastatic colorectal cancer (CRC)

dc.contributor.authorLee, Belinda
dc.contributor.authorAnton, Angelyn
dc.contributor.authorLee, Margaret
dc.contributor.authorWong, Rachel
dc.contributor.authorParente, Phillip
dc.contributor.authorShapiro, Jeremy D.
dc.contributor.authorYip, Desmond
dc.contributor.authorSteel, Simone Anne
dc.contributor.authorNott, L.
dc.contributor.authorStefanou, Gregory
dc.contributor.authorIddawela, Mahesh
dc.contributor.authorGibbs, Peter
dc.contributor.authorTran, Ben
dc.contributor.editorStephen A. Cannistra
dc.coverage.spatialSan Francisco, California, United States of America
dc.date.accessioned2020-08-18T02:30:19Z
dc.date.available2020-08-18T02:30:19Z
dc.date.createdJanuary 19-21, 2017
dc.date.issued2017
dc.date.updated2022-08-07T08:19:01Z
dc.description.abstractVolume: 35, Issue: Supplement 4, Abstract: 728
dc.format.mimetypeapplication/pdfen_AU
dc.identifier.isbn0732-183X
dc.identifier.issn0732-183Xen_AU
dc.identifier.urihttp://hdl.handle.net/1885/207837
dc.language.isoen_AUen_AU
dc.publisherAmerican Society of Clinical Oncology
dc.relation.ispartofseries2017 Gastrointestinal Cancers Symposiumen_AU
dc.rights© 2017 by American Society of Clinical Oncology
dc.sourceJournal of Clinical Oncology
dc.source.urihttp://ascopubs.org/toc/jco/35/4_supplen_AU
dc.titleExamining progression-free survival in first- and second-line treatment for BRAF-mutant metastatic colorectal cancer (CRC)
dc.typeConference paper
local.bibliographicCitation.issueS4en_AU
local.contributor.affiliationLee, Belinda, University of Melbourneen_AU
local.contributor.affiliationAnton, Angelyn, Peter MacCallum Cancer Centreen_AU
local.contributor.affiliationLee, Margaret, The Royal Melbourne Hospitalen_AU
local.contributor.affiliationWong, Rachel, Eastern Healthen_AU
local.contributor.affiliationParente , Phillip, Box Hill Hospitalen_AU
local.contributor.affiliationShapiro, Jeremy D., Monash Universityen_AU
local.contributor.affiliationYip, Desmond, College of Health and Medicine, The Australian National Universityen_AU
local.contributor.affiliationSteel, Simone Anne, Peninsula Private Hospitalen_AU
local.contributor.affiliationNott, L., Royal Hobart Hospitalen_AU
local.contributor.affiliationStefanou, Gregory, John Fawkner Private Hospitalen_AU
local.contributor.affiliationIddawela, Mahesh, Goulburn Valley Healthen_AU
local.contributor.affiliationGibbs, Peter, Royal Melbourne Hospitalen_AU
local.contributor.affiliationTran, Ben, Royal Melbourne Hospitalen_AU
local.contributor.authoruidYip, Desmond, u5086006en_AU
local.description.notesImported from ARIESen_AU
local.description.refereedYes
local.identifier.absfor111207 - Molecular Targetsen_AU
local.identifier.absseo920102 - Cancer and Related Disordersen_AU
local.identifier.ariespublicationu5234101xPUB256en_AU
local.identifier.citationvolume25en_AU
local.identifier.doi10.1200/JCO.2017.35.4_suppl.728en_AU
local.identifier.essn1527-7755en_AU
local.identifier.thomsonIDWOS:000443281700708
local.type.statusMetadata onlyen_AU

Downloads